{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T15:23:31Z","timestamp":1773761011259,"version":"3.50.1"},"reference-count":76,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","ajog.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1016\/j.ajog.2005.06.049","type":"journal-article","created":{"date-parts":[[2006,4,25]],"date-time":"2006-04-25T02:11:30Z","timestamp":1145931090000},"page":"1234-1242","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":80,"title":["17\u03b1-hydroxyprogesterone caproate for the prevention of preterm birth among women at increased risk: A systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1016","volume":"194","author":[{"given":"Roberta","family":"Mackenzie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Armson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary E.","family":"Hannah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2005.06.049_bib1","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1001\/jama.284.7.843","article-title":"The contribution of mild and moderate preterm birth to infant mortality","volume":"284","author":"Kramer","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2005.06.049_bib2","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJM200008103430601","article-title":"Neurologic and developmental disability after extremely preterm birth","volume":"343","author":"Wood","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2005.06.049_bib3","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/j.1471-0528.1998.tb10265.x","article-title":"Neonatal mortality amongst Scottish preterm singleton births (1985-1994)","volume":"105","author":"Magowan","year":"1998","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2005.06.049_bib4","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/0002-9378(93)90033-F","article-title":"Neonatal morbidity after preterm delivery in the presence of documented lung maturity","volume":"169","author":"Wigton","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2005.06.049_bib5","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0002-9378(12)90889-3","article-title":"A multicenter study of preterm birth weight and gestational age-specific neonatal mortality","volume":"168","author":"Copper","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2005.06.049_bib6","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1080\/jmf.13.4.218.223","article-title":"Cerebral morbidity in preterm twins","volume":"13","author":"Rettwitz-Volk","year":"2003","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2005.06.049_bib7","first-page":"488","article-title":"The cost of prematurity: quantification by gestational age and birth weight","volume":"102","author":"Gilbert","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2005.06.049_bib8","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1542\/peds.112.6.1290","article-title":"The impact of preterm birth on hospital admissions and costs during the first 5 years of life","volume":"112","author":"Petrou","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajog.2005.06.049_bib9","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM199811123392004","article-title":"Determinants of preterm birth rates in Canada from 1981 through 1983 and from 1992 through 1994","volume":"339","author":"Joseph","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2005.06.049_bib10","unstructured":"Health Canada. Canadian Perinatal Surveillance System. Canadian Perinatal Health Report 2003. Chapter 4;73-6. Available at: http:\/\/www.hc-sc.gc.ca\/pphb-dgspsp\/rhs-ssg\/index.html. Accessed July 10, 2005."},{"key":"10.1016\/j.ajog.2005.06.049_bib11","doi-asserted-by":"crossref","first-page":"F142","DOI":"10.1136\/fn.86.3.F142","article-title":"Socioeconomic status and preterm birth: New Zealand trends, 1980 to 1999","volume":"86","author":"Craig","year":"2002","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.ajog.2005.06.049_bib12","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S0002-9378(98)70439-9","article-title":"The preterm birth prediction study: risk factors for indicated preterm births","volume":"178","author":"Meis","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2005.06.049_bib13","doi-asserted-by":"crossref","first-page":"C81","DOI":"10.1152\/ajpcell.1980.238.3.C81","article-title":"Gap junction formation in myometrium: control by estrogens, 17\u03b1-hydroxyprogesterone caproate, and prostaglandins","volume":"238","author":"Garfield","year":"1980","journal-title":"Am J Physiol"},{"key":"10.1016\/j.ajog.2005.06.049_bib14","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0002-9378(16)41174-9","article-title":"Physiology of the corpus luteum: the comparative actions of crystalline progestin and crude progestin on uterine motility in unanesthetized rabbits","volume":"30","author":"Allen","year":"1935","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2005.06.049_bib15","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0002-9378(73)90517-6","article-title":"Effects of luteectomy and 17\u03b1-hydroxyprogesterone caproate replacement therapy in early pregnant patients","volume":"115","author":"Csapo","year":"1973","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2005.06.049_bib16","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1677\/joe.0.1240475","article-title":"Initiation of parturition and lactation in the sow: effects of delaying parturition with medroxyprogesterone acetate","volume":"124","author":"Whitely","year":"1990","journal-title":"J Endocrinol"},{"key":"10.1016\/j.ajog.2005.06.049_bib17","first-page":"65","article-title":"Double blind study of an agent to prevent preterm delivery among women at increased risk","author":"Papiernik","year":"1970","journal-title":"Edition Schering, Serie IV, fiche 3"},{"key":"10.1016\/j.ajog.2005.06.049_bib18","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1056\/NEJM197510022931401","article-title":"Efficacy of 17alpha-hydroxyprogesterone caproate in the prevention of premature labor","volume":"293","author":"Johnson","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2005.06.049_bib19","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa035140","article-title":"Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate","volume":"348","author":"Meis","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2005.06.049_bib20","first-page":"692","article-title":"System for predicting spontaneous preterm birth","volume":"55","author":"Creasy","year":"1980","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2005.06.049_bib21","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.ajog.2005.06.049_bib22","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/00003081-197312000-00012","article-title":"Pharmacologic control of premature labor","volume":"16","author":"Cibils","year":"1973","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.ajog.2005.06.049_bib23","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1111\/j.1471-0528.1965.tb01537.x","article-title":"Habitual abortion treated with 17\u03b1-hydroxyprogesterone capronate","volume":"72","author":"Cope","year":"1965","journal-title":"J Obstet Gynaecol Br Commonw"},{"key":"10.1016\/j.ajog.2005.06.049_bib24","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/0002-9378(93)90373-Q","article-title":"Preterm birth prevention: where are we?","volume":"168","author":"Creasy","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2005.06.049_bib25","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1471-0528.1989.tb02386.x","article-title":"Efficacy of 17\u03b1-hydroxyprogesterone caproate support for pregnancy in women with recurrent miscarriage: a meta-analysis of controlled trials","volume":"96","author":"Daya","year":"1989","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2005.06.049_bib26","first-page":"223","article-title":"Mechanism and prevention of preterm birth","volume":"163B","author":"Fuchs","year":"1985","journal-title":"Prog Clin Biol Res"},{"key":"10.1016\/j.ajog.2005.06.049_bib27","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1097\/00003081-198612000-00010","article-title":"Prevention of preterm labor and premature rupture of the membranes","volume":"29","author":"Gazaway","year":"1986","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.ajog.2005.06.049_bib28","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0095-5108(18)30725-5","article-title":"Prevention and treatment of preterm labor in twins","volume":"15","author":"Gilstrap","year":"1988","journal-title":"Clin Perinatol"},{"key":"10.1016\/j.ajog.2005.06.049_bib29","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1471-0528.1989.tb02385.x","article-title":"A meta-analysis of randomized control trials of progestational agents in pregnancy","volume":"96","author":"Goldstein","year":"1989","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2005.06.049_bib30","first-page":"412","article-title":"High-risk prematurity\u2014progestin treatment and steroid studies","volume":"54","author":"Johnson","year":"1979","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2005.06.049_bib31","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1471-0528.1990.tb01740.x","article-title":"Progestogen administration in pregnancy may prevent preterm delivery","volume":"97","author":"Kierse","year":"1990","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2005.06.049_bib32","first-page":"287","article-title":"Prophylactic use of hydroxyprogesterone caproate in abdominal surgery during pregnancy: a retrospective evaluation","volume":"46","author":"Hill","year":"1975","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2005.06.049_bib33","first-page":"198","article-title":"Hormonal therapy for control of the incompetent os of pregnancy","volume":"28","author":"Sherman","year":"1966","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2005.06.049_bib34","first-page":"1153","article-title":"Recent developments in preventing recurrent preterm birth","volume":"101","author":"Spong","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2005.06.049_bib35","first-page":"538","article-title":"Prevention of pre-term labour with 17\u03b1-hydroxyprogesterone caproate","volume":"69","author":"Suvonnakote","year":"1986","journal-title":"J Med Assoc Thailand"},{"key":"10.1016\/j.ajog.2005.06.049_bib36","first-page":"93","article-title":"Premature labor: its management and therapy","volume":"9","author":"Zuspan","year":"1972","journal-title":"J Reprod Med"},{"key":"10.1016\/j.ajog.2005.06.049_bib37","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0020-7292(82)90039-X","article-title":"Evaluation of the use of Proluton-Depot (hydroxyprogesterone hexanoate) in early pregnancy","volume":"20","author":"Varma","year":"1982","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ajog.2005.06.049_bib38","first-page":"702","article-title":"Correlated hormone excretion patterns and cytohormone variations in normal and complicated pregnancies; influence of administration of ovarian steroids or placebo in relation to outcome of pregnancy","volume":"93","author":"Nesbitt","year":"1965","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2005.06.049_bib39","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/bmj.1.5899.137","article-title":"17\u03b1-hydroxyprogesterone caproate deficiency and premature labour","volume":"1","author":"Csapo","year":"1974","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2005.06.049_bib40","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0002-9378(88)90127-5","article-title":"17\u03b1-hydroxyprogesterone caproate profiles in luteal phase defect cycles and outcome of 17\u03b1-hydroxyprogesterone caproate treatment in patients with recurrent spontaneous abortion","volume":"158","author":"Daya","year":"1988","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2005.06.049_bib41","first-page":"157","article-title":"The estimation of 17\u03b1-hydroxyprogesterone caproate in preterm delivery","volume":"50","author":"Franczak","year":"1995","journal-title":"Ann Univ Mariae Curie Sklodowska [Med]"},{"key":"10.1016\/j.ajog.2005.06.049_bib42","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1056\/NEJMoa002868","article-title":"Frequency of uterine contractions and the risk of spontaneous preterm delivery","volume":"346","author":"Iams","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2005.06.049_bib43","first-page":"26","article-title":"Utilisation de la 6-d\u00e9hydro-r\u00e9troprogest\u00e9rone en obst\u00e9trique. Indications, resultats","volume":"21","author":"Jamain","year":"1969","journal-title":"Bulletin de la Federation des Societes de Gynecologie et d'Obstetrique de Langue Francaise"},{"key":"10.1016\/j.ajog.2005.06.049_bib44","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/0002-9378(80)90137-4","article-title":"Suppression of threatened premature labor by administration of cortisol and 17\u03b1-hydroxyprogesterone caproate: a comparison with ritodrine","volume":"138","author":"Kauppila","year":"1980","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2005.06.049_bib45","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/j.1749-6632.1958.tb46806.x","article-title":"Clinical use of 17\u03b1-hydroxyprogesterone 17-n-caproate in habitual abortion","volume":"71","author":"Reifenstein","year":"1958","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.ajog.2005.06.049_bib46","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1136\/bmj.4.5936.67","article-title":"Endocrine changes in premature labour","volume":"4","author":"Raja","year":"1974","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2005.06.049_bib47","first-page":"5","article-title":"17\u03b1-hydroxyprogesterone caproate therapy of the inadequate luteal phase","volume":"6","author":"Wentz","year":"1982","journal-title":"Curr Probl Obstet Gynecol"},{"key":"10.1016\/j.ajog.2005.06.049_bib48","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0301-2115(01)00418-3","article-title":"A randomised trial of 17\u03b1-hydroxyprogesterone caproate prophylaxis after midtrimester amniocentesis","volume":"100","author":"Corrado","year":"2002","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2005.06.049_bib49","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0002-9378(83)91051-7","article-title":"The effect of 17\u03b1-hydroxyprogesterone caproate on pregnancy outcome in an active-duty military population","volume":"146","author":"Hauth","year":"1983","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2005.06.049_bib50","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0002-9378(16)35945-2","article-title":"Effect of medroxyprogesterone acetate upon the duration and characteristics of human gestation and labor","volume":"83","author":"Brenner","year":"1962","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2005.06.049_bib51","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1471-0528.1962.tb01176.x","article-title":"Controlled trials in the prophylactic value of 17\u03b1-hydroxyprogesterone caproate in the treatment of pre-eclamptic toxaemia","volume":"69","author":"Dalton","year":"1962","journal-title":"J Obstet Gynaecol Br Commonw"},{"key":"10.1016\/j.ajog.2005.06.049_bib52","first-page":"165","article-title":"Effets de la 17\u03b1-hydroxyprogesterone caproate naturelle micronisee sur le foie au cours du troisieme trimestre de la grossesse","volume":"25","author":"Benifla","year":"1997","journal-title":"Contracept Fertil Sex"},{"key":"10.1016\/j.ajog.2005.06.049_bib53","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0002-9378(86)90595-8","article-title":"The effects of oral administration of 17\u03b1-hydroxyprogesterone caproate for premature labor","volume":"154","author":"Erny","year":"1986","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2005.06.049_bib54","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/0002-9378(60)90381-1","article-title":"Treatment of threatened premature labor with large doses of 17\u03b1-hydroxyprogesterone caproate","volume":"79","author":"Fuchs","year":"1960","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2005.06.049_bib55","first-page":"26","article-title":"Double-blind controlled trial of 17\u03b1-hydroxyprogesterone caproate substitution in threatened abortion","volume":"8","author":"Gerhard","year":"1987","journal-title":"Biol Res Pregnancy Perinatol"},{"key":"10.1016\/j.ajog.2005.06.049_bib56","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1111\/j.1471-0528.1965.tb01536.x","article-title":"A double-blind study of progestogen treatment in spontaneous abortion","volume":"72","author":"Govaerts-Videtzky","year":"1965","journal-title":"J Obstet Gynaecol Br Commonw"},{"key":"10.1016\/j.ajog.2005.06.049_bib57","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/j.1471-0528.1965.tb01540.x","article-title":"Double-blind controlled trial of 6-methyl, 17-acetoprogesterone in threatened abortion","volume":"72","author":"Moller","year":"1965","journal-title":"J Obstet Gynaecol Br Commonw"},{"key":"10.1016\/j.ajog.2005.06.049_bib58","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0028-2243(91)90118-5","article-title":"The use of micronized 17\u03b1-hydroxyprogesterone caproate in the treatment of menace of preterm delivery","volume":"40","author":"Noblot","year":"1991","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2005.06.049_bib59","first-page":"1227","article-title":"Traitement par la progest\u00e9rone des menaces d'accouchement pr\u00e9matur\u00e9 avec taux bas de 17\u03b1-hydroxyprogesterone caproate plasmatique","volume":"13","author":"Sondergaard","year":"1985","journal-title":"Contracept Fertil Sex"},{"key":"10.1016\/j.ajog.2005.06.049_bib60","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0090-6980(80)90080-5","article-title":"Therapeutic value of indomethacin in threatened abortion","volume":"19","author":"Souka","year":"1980","journal-title":"Prostaglandins"},{"key":"10.1016\/j.ajog.2005.06.049_bib61","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/S0140-6736(80)92496-4","article-title":"Progestagens in threatened abortion","volume":"316","author":"Tognoni","year":"1980","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2005.06.049_bib62","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1136\/bmj.1.4819.1073","article-title":"17\u03b1-hydroxyprogesterone caproate implantation in habitual abortion","volume":"I","author":"Swyer","year":"1953","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2005.06.049_bib63","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3109\/09513598709030681","article-title":"Trial of 17-hydroxyprogesterone caproate (Proluton Depot) in women with long-standing infertility; failure of estrogen positive feedback the following cycle","volume":"1","author":"Mavroudis","year":"1987","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ajog.2005.06.049_bib64","first-page":"692","article-title":"Inefficacy of 17 alpha-hydroxprogesterone caproate in the prevention of prematurity in twin pregnancy","volume":"56","author":"Hartikainen-Sorri","year":"1980","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2005.06.049_bib65","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1001\/jama.1964.03060330031008","article-title":"Double blind trial of a progestin in habitual abortion","volume":"188","author":"Goldzieher","year":"1964","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2005.06.049_bib66","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1111\/j.1471-0528.1965.tb01533.x","article-title":"Hormones in recurrent abortion","volume":"72","author":"Klopper","year":"1965","journal-title":"J Obstet Gynaecol Br Commonw"},{"key":"10.1016\/j.ajog.2005.06.049_bib67","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1136\/bmj.1.5326.292","article-title":"Double-blind study of effect of 17-hydroxyprogesterone caproate on abortion rate","volume":"5326","author":"Shearman","year":"1963","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2005.06.049_bib68","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/0002-9378(85)90141-3","article-title":"Prevention of premature labor by 17\u03b1-hydroxyprogesterone caproate","volume":"151","author":"Yemini","year":"1985","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2005.06.049_bib69","first-page":"30","article-title":"Habitual abortion: a controlled study of progestational therapy","volume":"72","author":"LeVine","year":"1964","journal-title":"West J Surg Obstet Gynecol"},{"key":"10.1016\/j.ajog.2005.06.049_bib70","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/0002-9378(66)90173-6","article-title":"Prolonged gynecologic and endocrine manifestations subsequent to administration of medroxyprogesterone acetate during pregnancy","volume":"95","author":"Turner","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2005.06.049_bib71","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1067\/mob.2003.41","article-title":"Prophylactic administration of 17\u03b1-hydroxyprogesterone caproate by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study","volume":"188","author":"Da Fonseca","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2005.06.049_bib72","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1056\/NEJM197104222841604","article-title":"Association of maternal stilbestrol therapy with tumor appearance in young women","volume":"284","author":"Herbst","year":"1971","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2005.06.049_bib73","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJM199602293340904","article-title":"The length of the cervix and the risk of spontaneous premature delivery","volume":"334","author":"Iams","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2005.06.049_bib74","first-page":"685","article-title":"Prospective risk of fetal death in singleton, twin, and triplet gestations: implications for practice","volume":"102","author":"Kahn","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2005.06.049_bib75","series-title":"A word processing, database and statistics program for public health","article-title":"Epi Info 6","author":"Centers for Disease Control and Prevention","year":"1996"},{"key":"10.1016\/j.ajog.2005.06.049_bib76","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/01.AOG.0000150559.59531.b2","article-title":"Progestational agents to prevent preterm birth: a meta-analysis of randomized controlled trials","volume":"105","author":"Sanchez-Ramos","year":"2005","journal-title":"Obstet Gynecol"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293780500894X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293780500894X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T11:38:23Z","timestamp":1715945903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000293780500894X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":76,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S000293780500894X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2005.06.049","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2006,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"17\u03b1-hydroxyprogesterone caproate for the prevention of preterm birth among women at increased risk: A systematic review and meta-analysis of randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2005.06.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Mosby, Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}